Assistant Professor, Internal Medicine, University Kansas School of Medicine
Hematology
Dr. Kelly B. Pendergrass, MD
|
|
Give Review
Kelly B. Pendergrass, MD is an expert in the field of Hematology. He went to medical school at University of Kansas School of Medicine. He over the years received 2 awards: "Super Doctor" and "Top MD". Kelly Pendergrass is a published doctor and has 17 publications published. The lastest was: 'Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group.' Kelly Pendergrass accepts Medicare payments and is registered with Medicare.gov.
Publications
- Phase III, double-blind, controlled trial of atamestane plus toremifene compared with letrozole in postmenopausal women with advanced receptor-positive breast Cancer.
- Efficacy of oral ondansetron, a selective antagonist of 5-HT3 receptors, in the treatment of nausea and vomiting associated with cyclophosphamide-based chemotherapies....
- Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast Cancer.
- High-dose chemotherapy and peripheral blood stem cell infusion in patients with non-Hodgkin''s lymphoma: results of outpatient treatment in community Cancer centers.
- ReDuction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group.
- Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of...
- A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associ...
- Prevention of Acute emesis in cancer patients following high-dose cisplatin with the combination of oral dolasetron and dexamethasone.
- Oral dolasetron mesylate in patients receiving moderately emetogenic platinum-containing chemotherapy. Oral Dolasetron Dose Response Study Group.
- Randomized phase III study of 5-fluorouracil plus high dose folinic acid versus 5-fluorouracil plus folinic acid plus methyl-lomustine for patients with advanced color...
- Intensive timed sequential combination chemotherapy in extensive-stage small cell Carcinoma of the lung.
- Unfavorable histologies of non-Hodgkin's Lymphoma treated with ProMACE-CytaBOM: a groupwide Southwest Oncology Group study.
- Options in the treatment of chemotherapy-induced emesis.
- Aprepitant: an oral NK1 antagonist for the prevention of nausea and vomiting induced by highly emetogenic chemotherapy.
- Randomized, placebo-controlled, phase III study of first-line oxaliplatin-based chemotherapy plus PTK787/ZK 222584, an oral vascular endothelial growth factor receptor...
- Results of the CONFIRM phase III trial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor-positive advanced Breast can...
Schools
University of Kansas School of Medicine
Baptist Memorial Hospital Memphis
Brown University
Johns Hopkins University
Procedures Preformed
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Awards
- Super Doctor
- Top MD
Education
-
University of Kansas School of Medicine
Drug Facts
| NPI NUMBER | 1639140221 | |
| NPPES Provider LastName | PENDERGRASS | |
| NPPES Provider FirstName | KELLY | |
| NPPES Provider ZIPCode | 641313366 | |
| NPPES Provider State | MO | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 671.0 | |
| Distinct Opioid Count | 4.0 | |
| Opioid Claim Count | 64.0 | |
| Percent Opioid Claims | 9.54 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1639140221 |
| Last Name Of The Provider | PENDERGRASS |
| First Name Of The Provider | KELLY |
| View All |
Similar Doctors
|
Dr. Karl H. Hanson Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Mary Kellam, NP
This Doctor is OpenDoctor Recommended.
|
|
Dr. Robert E. Pluenneke, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jamie P. Rigden, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Maureen H. Sheehan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark T. Stivers, MD |
|
|
Dr. Stephen R. Smalley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Timothy J. Pluard, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. William T. Stephenson, MD |
|
Dr. John M. Davis II, MD |
|
|
Dr. Richard A. Johnson, DO |
|
|
Rakesh Gaur, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sheshadri Madhusudhana, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abdulraheem M. Qasem, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chester W. Stone, MD |
|
|
Dr. Rudy L. Edwards, DO |
|
|
Weijie Li, MB CHB
This Doctor is OpenDoctor Recommended.
|